GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Atricure, Inc. (ATRC) [hlAlert]

Rating:
Buy ATRC
up 140.34 %

Atricure, Inc. (ATRC) rated Buy

Posted on: Tuesday,  Oct 9, 2007  9:25 AM ET by Stanford Research

Stanford Research rated Buy Atricure, Inc. (NASDAQ: ATRC) on 10/09/2007, when the stock price was $10.93. Since
then, Atricure, Inc. has gained 140.35% as of 01/06/2016's recent price of $26.27.
If you would have followed this Stanford Research's recommendation on ATRC, you would have gained 140.34% of your investment in 3011 days.

AtriCure, Inc. is a medical device company that develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue. The Company's primary product line, which accounts for a majority of its revenues, is the AtriCure Isolator system. AtriCure's Isolator system consists primarily of a compact power generator known as an ablation and sensing unit (ASU), a switchbox unit (ASB), which allows physicians to toggle between multiple products and multiple configurations of its Isolator clamps, including its Isolator Synergy clamps. AtriCure also sells a multifunctional bipolar pen, or multifunctional pen, which is often used by physicians in combination with its Isolator system to ablate cardiac tissue and for temporary pacing, sensing, stimulating and recording during the evaluation of cardiac arrhythmias. In 2008, The Company received FDA approval for its EXCLUDE clinical trial.

Stanford Research encompasses both institutional equity research and Washington-focused policy research, offering a perspective on individual companies, sector-specific topics and national policy. The importance Stanford Group Company places on research comes from years of experience in a constantly changing world. We know that as markets develop and new sectors grow, it is imperative that our clients have the most accurate information available to ensure financial success. Stanford Group Company clients will always have our commitment to conduct informative and enlightening research. As a part of our commitment to our clients, we provide objective, well-developed research. Our skilled analysts use their talent to provide invaluable research that can help in making important decisions. Thanks to a wide range of resources obtained through technology, experience and reputation, our research analysts develop reports on the most current firms and sectors. Our equity analysts offer insight and opinions on companies in the consumer/retail, media, energy, financial institutions, health care, technology and water/environment sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/9/2007 9:25 AM Buy
None
10.93
as of 8/27/2015
1 Week down  -2.52 %
1 Month up  7.66 %
3 Months up  20.00 %
1 YTD up  40.63 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy